Canan Ersoy

The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients

Canan Ersoy, Ferah Budak, Haluk Barbaros Oral et al. · Diabetes Research and Clinical Practice · 2008 · 124 citations

Obesity, Metabolic Syndrome, Diabetes Management +9

Serum Monocyte Chemoattractant Protein-1 and Monocyte Adhesion Molecules in Type 1 Diabetic Patients with Nephropathy

Erdinç Ertürk, Ferah Budak, Canan Ersoy et al. · Archives of Medical Research · 2006 · 44 citations

Inflammation, Type 1, Renal Function +12

Relation between insulin resistance and serum concentrations of IL-6 and TNF-α in overweight or obese women with early stage breast cancer

Güzin Gönüllü, Canan Ersoy, Alpaslan Ersoy et al. · Cytokine · 2005 · 35 citations

Obesity, Metabolic Syndrome, Insulin Resistance +11

Effect Of Levothyroxine Treatment On Qt Dispersion In Patients With Subclinical Hypothyroidism

Oguzkaan Unal, Erdinç Ertürk, Hakan Özkan et al. · Endocrine Practice · 2007 · 34 citations

Thyroid Disease, Qt Dispersion, Thyroid Disorders +3

Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)

Alper Sönmez, Cem Haymana, Fahrı Bayram et al. · Diabetes Research and Clinical Practice · 2018 · 32 citations

Obesity, Nutrition, Metabolic Syndrome +11